0.7858

1.79% -0.0142

T 2 Biosystems Inc (TTOO)

Overview News Price History Financials Why TTOO Down? Discussions Forecast Stock Split

T 2 Biosystems Inc stock is traded at $0.7858, with a volume of 257.11K. It is down -1.79% in the last 24 hours and down -56.83% over the past month. T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Previous Close:

$0.80

Open:

$0.7933

24h Volume:

257.11K

Relative Volume:

0.67

Market Cap:

$13.98M

Revenue:

$7.19M

Net Income/Loss:

$-50.08M

P/E Ratio:

-0.00274

EPS:

-286.9

Net Cash Flow:

$-48.33M

1W Performance:

-18.83%

1M Performance:

-56.83%

6M Performance:

-78.88%

1Y Performance:

-85.48%

1-Day Range:

$0.78

$0.825

1-Week Range:

$0.775

$0.99

52-Week Range:

$0.775

$8.3799

T 2 Biosystems Inc Stock (TTOO) Company Profile

Name

T 2 Biosystems Inc

Sector

Healthcare (1181)

Industry

Diagnostics & Research (57)

Phone

781-457-1200

Address

101 HARTWELL AVENUE, LEXINGTON

Employee

113

Twitter

@T2Bio

Next Earnings Date

2024-11-04

Latest SEC Filings

TTOO's Discussions on Twitter

T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-21	Downgrade	Alliance Global Partners	Buy → Neutral
Oct-08-20	Initiated	BTIG Research	Buy
Nov-26-19	Downgrade	Janney	Buy → Neutral
Aug-01-19	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-31-19	Downgrade	H.C. Wainwright	Buy → Neutral
Jul-31-19	Downgrade	Janney	Buy → Neutral
May-16-19	Initiated	Alliance Global Partners	Buy
Mar-08-19	Reiterated	H.C. Wainwright	Buy
Jun-01-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
May-30-18	Reiterated	H.C. Wainwright	Buy
May-29-18	Reiterated	WBB Securities	Strong Buy
Mar-29-18	Reiterated	H.C. Wainwright	Buy
Jan-29-18	Initiated	Goldman	Neutral
Oct-18-17	Initiated	H.C. Wainwright	Buy
Mar-15-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-10-16	Resumed	Leerink Partners	Mkt Perform
Nov-02-16	Reiterated	Cantor Fitzgerald	Buy
Jul-20-16	Upgrade	WBB Securities	Buy → Strong Buy
Jun-22-16	Upgrade	WBB Securities	Speculative Buy → Buy
Apr-12-16	Reiterated	Canaccord Genuity	Buy
Feb-17-16	Initiated	WBB Securities	Speculative Buy

View All

T 2 Biosystems Inc Stock (TTOO) Latest News

08:13 AM

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewswire

08:13 AM

Nov 04, 2024

T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - MPO-mag

Nov 04, 2024

T2 Biosystems stock plunges to 52-week low of $0.81 - Investing.com

Nov 04, 2024

Oct 25, 2024

T2 Biosystems stock plunges to 52-week low at $1.08 By Investing.com - Investing.com Australia

Oct 25, 2024

T2 Biosystems stock plunges to 52-week low at $1.08 - Investing.com

Oct 25, 2024

Oct 17, 2024

T2 Biosystems stock plunges to 52-week low of $1.37 - Investing.com

Oct 17, 2024

T2 Biosystems stock plunges to 52-week low of $1.37 By Investing.com - Investing.com UK

Oct 17, 2024

Oct 16, 2024

T2 Biosystems reports progress in product pipeline By Investing.com - Investing.com South Africa

Oct 16, 2024

T2 Biosystems reports progress in product pipeline - Investing.com India

Oct 16, 2024

Oct 11, 2024

Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships By Investing.com - Investing.com South Africa

Oct 11, 2024

Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships - Investing.com

Oct 11, 2024